Beam Therapeutics (NASDAQ:BEAM) Upgraded at Jones Trading
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by Jones Trading from a “hold” rating to a “buy” rating in a report released on Monday,Benzinga reports. The brokerage presently has a $34.00 target price on the stock. Jones Trading’s price objective would suggest a potential upside of 28.69% from the stock’s current price. Several […]
Beam Therapeutics (NASDAQ:BEAM – Get Free Report) was upgraded by Jones Trading from a “hold” rating to a “buy” rating in a report released on Monday,Benzinga reports. The brokerage presently has a $34.00 target price on the stock. Jones Trading’s price objective would suggest a potential upside of 28.69% from the stock’s current price. Several […]
